Evidence map›Paper›PMID 31538117›Full record

ArticleHeliyon2019

The inhibitory effects of an eight-herb formula (RCM-107) on pancreatic lipase: enzymatic,

Shiqi Luo, Harsharn Gill, Daniel Anthony Dias, Mingdi Li, Andrew Hung, Linh Toan Nguyen, George Binh Lenon

Open access · goldAbstract read
In one paragraph

Article in Heliyon, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
9.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Unraveling the Impact ofFoods (Basel, Switzerland) · 2024
    Article
  5. Review
  6. Heliyon · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Shiqi LuoSchool of Health and Biomedical Sciences, RMIT University, Bundoora West Campus, Victoria, 3083, Australia.
Harsharn GillSchool of Science, RMIT University, Bundoora West Campus, Victoria, 3083, Australia.
Daniel Anthony DiasSchool of Health and Biomedical Sciences, RMIT University, Bundoora West Campus, Victoria, 3083, Australia.
Mingdi LiSchool of Health and Biomedical Sciences, RMIT University, Bundoora West Campus, Victoria, 3083, Australia.
Andrew HungSchool of Science, RMIT University, Bundoora West Campus, Victoria, 3083, Australia.
Linh Toan NguyenDepartment of Endocrine, 103 Military Hospital, Vietnam Military Medical University, Hanoi, Viet Nam.
George Binh LenonSchool of Health and Biomedical Sciences, RMIT University, Bundoora West Campus, Victoria, 3083, Australia.
RMIT University · AUVietnam Military Medical University · VN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsObesity is a global, public health issue that causes or exacerbates serious medical disorders. Chinese herbal therapies have become one of the most popular alternatives due to intolerances of current anti-obesity treatments. The RCM-107 formula (granule) is modified from our previous studied RCM-104 formula, which has demonstrated significant effects on weight reduction in randomized clinical trials. Up to date, there is no published scientific evidence to evaluate the effect of this formula on the weight-loss target pancreatic lipase and therefore, the aim of this study is to investigate the inhibitory effect of RCM-107 and respective individual ingredient on the pancreatic lipase activities. MAIN

methodsFluorometric based enzymatic assays, high-performance thin-layer chromatography (HPTLC) profiling and PRINCIPLE

findingsThe results demonstrated the potent lipase suppressing effect of the RCM-107 formula. The majority of the ingredients from this formula also showed pancreatic lipase inhibitory activities. The presence of the known weight-loss compounds such as (-)-epigallocatechin-3-gallate (EGCG), epicatechin-3-gallate (ECG), (-)-epicatechin (EC), rutin, crocin and caffeine were identified in the RCM-107 and related single herbs using HPTLC profiling approaches. In addition, EGCG, EC and the known lipase antagonist orlistat acted on the same site. These compounds form hydrogen bonds with corresponding residues HIS152, ASP80 and GLY77, which can be considered as markers of important areas in the ligand-binding site. This may explain the details of their roles in inhibiting pancreatic lipase activities.

conclusionOur data has provided new knowledge to the mechanistic properties of the RCM-107 formula and its respective individual herbal ingredients for weight loss, in terms of reducing lipid absorption via the inhibition of pancreatic lipase.

Indexed as

Alternative medicineAnalytical chemistryCatechinsComputational chemistryDockingEvidence-based medicineHigh-performance thin layer chromatography (HPTLC)Lipase inhibitionMolecular biologyObesityTraditional Chinese medicine

Identifiers

PMID31538117
PMCPMC6745409
OpenAlexW2972562186

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.